Difficulty: Medium
Average Score: 86%
Practice
Several years later, Mr. Hunter, who is now 75 years old, seeks additional intervention for his urinary symptoms that have progressed further. He now experiences slow urinary stream, hesitancy, straining, and a feeling of incomplete emptying in addition to the previous urinary urgency and frequency. At times, he has noted blood in his urine. He has had five urinary tract infections (UTIs) in the past 2 years. His current IPSS is 24, with a bother score of 5 indicating severe voiding symptoms with high impact on his quality of life. Mr. HunterÔÇÖs updated medical history includes hypertension, coronary artery disease, benign prostatic hyperplasia, cataract surgery 4 years ago, and two falls within the past year while rushing to the bathroom during the night. Current medications are aspirin, metoprolol, finasteride, and tamsulosin. Physical examination reveals an enlarged, nontender prostate, about 50 g in size without discrete nodules. Upon further evaluation, the intermittent hematuria is attributed to BPH. Postvoid residual volume is 110 mL. Uroflowmetry reveals urinary flow rate of 12 mL/s. Which of the following is the best next step in management?
Correct answer
D
Rationale
The best next step in the management of Mr. Hunter's condition is to perform surgical resection of the prostate (Option D). This is the most appropriate course of action considering his severe voiding symptoms, high impact on quality of life, recurrent UTIs, significant postvoid residual volume, and low urinary flow rate. Surgical resection, such as transurethral resection of the prostate (TURP), is a common and effective treatment for benign prostatic hyperplasia (BPH) when medical therapy (such as tamsulosin and finasteride) is insufficient.
Option A (Start tadalafil) is not the best choice in this case because tadalafil is a medication used for erectile dysfunction and pulmonary arterial hypertension, not for the treatment of BPH-related urinary symptoms.
Option B (Switch from tamsulosin to silodosin) may not address the severity of Mr. Hunter's symptoms and the need for more definitive intervention like surgery.
Option C (Switch from finasteride to dutasteride) involves changing the type of 5-alpha reductase inhibitor, which may not provide significant improvement in symptoms necessitating a more aggressive approach like surgical resection.
In an educational context, understanding the progressive nature of BPH and the indications for surgical management is crucial for healthcare providers involved in the care of patients with urinary symptoms. It is important to recognize when conservative measures are no longer sufficient and when surgical intervention is necessary to improve symptoms and prevent complications.
Option A (Start tadalafil) is not the best choice in this case because tadalafil is a medication used for erectile dysfunction and pulmonary arterial hypertension, not for the treatment of BPH-related urinary symptoms.
Option B (Switch from tamsulosin to silodosin) may not address the severity of Mr. Hunter's symptoms and the need for more definitive intervention like surgery.
Option C (Switch from finasteride to dutasteride) involves changing the type of 5-alpha reductase inhibitor, which may not provide significant improvement in symptoms necessitating a more aggressive approach like surgical resection.
In an educational context, understanding the progressive nature of BPH and the indications for surgical management is crucial for healthcare providers involved in the care of patients with urinary symptoms. It is important to recognize when conservative measures are no longer sufficient and when surgical intervention is necessary to improve symptoms and prevent complications.